Pure Global AI
LMHRA DOC-GDL-009

DOC-GDL-009

Guidelines on Post-Authorization Safety Studies
LiberiaLiberia Medicines and Health Products Regulatory AuthorityVigilanceEffective 2026-04-16
Official source linked
What this code is

DOC-GDL-009 is the official LMHRA identifier for “Guidelines on Post-Authorization Safety Studies”. DOC-GDL-009 is the official identifier LMHRA uses for this instrument.

Instrument
DOC-GDL-009
Full name
DOC-GDL-009
Category
Vigilance
Source links
Source publication
English
Open the source text
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Read the full text →
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
2026-04-16
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

English full textEnglish — original textRead HTML →
About this regulation

Guidelines on Post-Authorization Safety Studies

Complete official 20-page LMHRA guideline issued 13 April 2026 and implemented 16 April. Definitions and assessment provisions explicitly include medical devices; contains submissions, review, amendments, reporting and annexed checklist. The cover says Version 003 while its document-control field says Version 01; both are retained as printed rather than resolved by assumption.

DOC-GDL-009 is the official identifier LMHRA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.

Source linked